TCGX Acquisition Corp. (NASDAQ:TCGX) Financings

TCGX Acquisition Corp.

Financings

RaiseDate
Private placement of common stock (PIPE)
Announced: US$160M · US$10 a share · Jefferies +3
Dealers: Jefferies (co-lead), TD Cowen (co-lead), Cantor, LifeSci Capital
Buyers: TCGX; Viking Global Investors; ADAR1 Capital Management; BVF Partners; Samsara BioCapital; Vianti Capital
Use of proceeds: Complete Phase 3 trials of elismetrep and submit an NDA, run a migraine prevention trial, and prepare for a potential U.S. launch
Oct 19, 2026
Public offering of class A ordinary shares
Closed: US$10 a share · Jefferies
Dealers: Jefferies (lead)
Aug 6, 2026

Read by 6ix AI from the company's releases